Cargando…

Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria

Erythropoietic protoporphyria (EPP) is a rare genetic disease in which patients experience acute phototoxic reactions after sunlight exposure. It is caused by a deficiency in ferrochelatase (FECH) in the heme biosynthesis pathway. Most patients exhibit a loss-of-function mutation in trans to an alle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halloy, François, Iyer, Pavithra S, Ćwiek, Paulina, Ghidini, Alice, Barman-Aksözen, Jasmin, Wildner-Verhey van Wijk, Nicole, Theocharides, Alexandre P A, Minder, Elisabeth I, Schneider-Yin, Xiaoye, Schümperli, Daniel, Hall, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Chemical Biology and Nucleic Acid Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229840/ https://www.ncbi.nlm.nih.gov/pubmed/32313951 http://dx.doi.org/10.1093/nar/gkaa229

Ejemplares similares

Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2017)

Current trials in erythropoietic protoporphyria: are placebo controls ethical?
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)

Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2020)

Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study
por: Barman-Aksözen, Jasmin, et al.
Publicado: (2023)

Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study
por: Minder, Anna-Elisabeth, et al.
Publicado: (2021)

Heme Biosynthetic Gene Expression Analysis With dPCR in Erythropoietic Protoporphyria Patients
por: Granata, Francesca, et al.
Publicado: (2022)

Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009)

Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria
por: Minder, Anna-Elisabeth, et al.
Publicado: (2023)

Level of Expression of the Nonmutant Ferrochelatase Allele is a Determinant of Biochemical Phenotype in a Mouse Model of Erythropoietic Protoporphyria
por: Bloomer, Joseph, et al.
Publicado: (2008)

Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022)

How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023)

The role of ClpX in erythropoietic protoporphyria
por: Whitman, Jared C., et al.
Publicado: (2018)

UK experience of liver transplantation for erythropoietic protoporphyria
por: Dowman, Joanna K., et al.
Publicado: (2011)

Laparoscopic Cholecystectomy in a Patient with Erythropoietic Protoporphyria
por: Roe, Thomas, et al.
Publicado: (2010)

Advances in the management of erythropoietic protoporphyria – role of afamelanotide
por: Lane, Ashley M, et al.
Publicado: (2016)

Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020)

A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
por: Balwani, Manisha, et al.
Publicado: (2022)

An Unusual Case of Erythropoietic Protoporphyria Mimicking Lipoid Proteinosis
por: Kaur, Sarabjit, et al.
Publicado: (2019)

Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy
por: Yoshida, Akihiro, et al.
Publicado: (2018)

Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria
por: Di Pierro, Elena, et al.
Publicado: (2022)

Erythropoietic protoporphyria: Delayed presentation with decompensated liver disease
por: Sarda, Radhika, et al.
Publicado: (2020)

Erythropoietic protoporphyria: case reports for clinical and therapeutic hints
por: Tumminelli, Cristina, et al.
Publicado: (2023)

Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X‐linked protoporphyria
por: Naik, Hetanshi, et al.
Publicado: (2019)

Prevention of photosensitivity with action spectrum adjusted protection for erythropoietic protoporphyria
por: Teramura, Takashi, et al.
Publicado: (2017)

The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria
por: Wang, Pengcheng, et al.
Publicado: (2019)

Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
por: Biolcati, G., et al.
Publicado: (2021)

Erythropoietic Protoporphyria Masquerading as Angioedema in a 4-Year-Old Female
por: Wang, Helen C, et al.
Publicado: (2006)

Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria
por: Park, Pyoung-Jae, et al.
Publicado: (2012)

Bovine congenital erythropoietic protoporphyria in a crossbred limousin heifer in Ireland
por: McAloon, Conor G., et al.
Publicado: (2015)

Delayed photosensitivity in a child with erythropoietic protoporphyria : a case report
por: Kiberd, James, et al.
Publicado: (2018)

Diagnosis of erythropoietic protoporphyria with severe liver injury: A case report
por: Liu, Hui-Min, et al.
Publicado: (2019)

Management of erythropoietic protoporphyria with cholestatic liver disease: A case report
por: Poli, Antoine, et al.
Publicado: (2023)

RNase H sequence preferences influence antisense oligonucleotide efficiency
por: Kiełpiński, Łukasz J., et al.
Publicado: (2017)

Correction to: Validation of a novel patient reported tool to assess the impact of treatment in erythropoietic protoporphyria: the EPP-QoL
por: Biolcati, G., et al.
Publicado: (2021)

Mechanisms of covalent self-assembly of the Azoarcus ribozyme from four fragment oligonucleotides
por: Draper, Will E., et al.
Publicado: (2008)

Patient-recorded outcome to assess therapeutic efficacy in protoporphyria-induced dermal phototoxicity: a proposal
por: Minder, Elisabeth I, et al.
Publicado: (2010)

The 6-year follow-up of a Japanese patient with silent erythropoietic protoporphyria
por: Mizawa, Megumi, et al.
Publicado: (2017)

Microvascular Hepatic Artery Anastomosis in Living Donor Liver Transplantation for Erythropoietic Protoporphyria
por: Yamashita, Shuji, et al.
Publicado: (2020)

Characterization of a novel pathogenic variant in the FECH gene associated with erythropoietic protoporphyria
por: Kieke, Michele C., et al.
Publicado: (2019)

Erythropoietic Protoporphyria: You May Not Have Seen It, but It May Have Seen You
por: Pastore, Larissa M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_79bbvo6snhbqkrurcbh8j51anj